Description
PTA2 is a stable analog of TXA2. It is a TP receptor antagonist and an inhibitor of TX synthase.{516,794} PTA2 inhibits U-46619-induced cat coronary artery constriction (ID50 = 0.1 µM), U-46619-induced aggregation of human platelets (IC50 = 2 µM), and rabbit platelet TX synthase (ID50 = 50 µM). PTA2 does not affect PGI synthase up to a concentration of 100 µM.{516}
Formal name: 9α,11α-(dimethyl)methylene-15S-hydroxy-11a-deoxy-11a-methylene-thromba-5Z,13E-dien-1-oic
Synonyms: 15(S)-Pinane Thromboxane A2|Pinane TXA2|PTA2
Molecular weight: 376.6
CAS: 71111-01-8
Purity: ≥98%
Formulation: A solution in ethanol
Product Type|Biochemicals|Lipids|Thromboxanes||Product Type|Biochemicals|Receptor Pharmacology|Antagonists||Product Type|Biochemicals|Small Molecule Inhibitors||Research Area|Cardiovascular System|Blood|Thrombosis||Research Area|Cardiovascular System|Cardiovascular Diseases|Coronary Artery Disease||Research Area|Lipid Biochemistry|Cyclooxygenase Pathway